Shilpa Medicare
SHILPAMED
Pharma₹1,064.00
Price as of 3 Oct 2026, 1:02 pm IST
Market cap ₹20,810 Cr
- P/E
- 69.91
- Day range
- ₹1,034.60 – ₹1,095.00
- 52-week range
- ₹259.50 – ₹1,095.00
- Volume
- 16.88 L
- Open
- ₹1,044.00
- Prev close
- ₹1,047.20
1 red flag to read up on
- high
Under Additional surveillance (ASM)
The exchange has put this stock under Additional surveillance (ASM), Stage I · 2 Oct 2026
From NSE and BSE filings. A flag is a reason to read the filing, not a rating.
SHILPAMED in NSE indices and F&O
Research profile
Derived metrics
- Earn. yield
- 1.4%
Appears in 1 scans
Percentiles rank this stock against the other tracked stocks and change as they do. Scans describe where figures sit today. Hover a label for its definition. Not investment advice.
Peer comparison
All 66 in Pharma| Company | M-cap | P/E | P/B | ROE | ROCE | OPM | D/E | Sales YoY |
|---|---|---|---|---|---|---|---|---|
| Sun PharmaSUNPHARMA | ₹4.32 L Cr | 35.71 | 5.18 | 14.8% | 21.0% | 29.0% | 0.06 | +10.5% |
| Divi's LaboratoriesDIVISLAB | ₹2.46 L Cr | 84.04 | 14.66 | 16.2% | 22.0% | 41.0% | 0.00 | +27.8% |
| Torrent PharmaTORNTPHARM | ₹1.81 L Cr | 76.34 | 19.22 | 26.8% | 15.0% | 34.0% | 1.79 | +54.8% |
| Apollo HospitalsAPOLLOHOSP | ₹1.17 L Cr | 55.87 | 13.60 | 22.6% | 17.0% | 16.0% | 0.90 | +20.6% |
| Zydus LifesciencesZYDUSLIFE | ₹1.14 L Cr | 25.51 | 4.26 | 20.1% | 21.0% | 24.0% | 0.46 | +22.0% |
| CiplaCIPLA | ₹1.09 L Cr | 32.26 | 3.20 | 11.8% | 15.0% | 17.0% | 0.02 | +2.3% |
| Laurus LabsLAURUSLABS | ₹1.07 L Cr | 98.02 | 20.20 | 18.2% | 18.0% | 32.0% | 0.48 | +29.0% |
| Shilpa MedicareSHILPAMED | ₹20,810 Cr | 69.91 | — | — | — | — | — | — |
| Sector median | ₹26,237 Cr | 45.27 | 7.05 | 15.5% | 17.0% | 24.5% | 0.18 | +20.7% |
Sector as classified in the tracked universe; medians use every tracked Pharma company, and P/E only profitable ones. Tinted figures beat the median.
Financials not yet synced
This company is tracked, but its filings have not been processed yet. Results appear here once the next sync reaches it.
Corporate actions
No dividends, splits or bonuses recorded for this company yet.
FAQ
Shilpa Medicare: common questions
Answered from the figures on this page.
Shilpa Medicare last traded at ₹1,064.00 (NSE, as of 3 Oct 2026). The last session moved it up 1.60%.
Shilpa Medicare is valued at about ₹20,810 crore (NSE, as of 3 Oct 2026).
Shilpa Medicare trades at a price-to-earnings ratio of 69.91 (NSE, as of 3 Oct 2026). The P/E compares the share price with earnings per share, so it is only comparable between companies in the same industry.
Shilpa Medicare has traded between ₹259.50 and ₹1,095.00 over the past 52 weeks, to 3 Oct 2026. It is currently 96% of the way up that range.
Shilpa Medicare (SHILPAMED) is classified under Pharma on this site's screener.
